...
首页> 外文期刊>Journal of cardiovascular electrophysiology >Temporal trends in safety and complication rates of catheter ablation for atrial fibrillation
【24h】

Temporal trends in safety and complication rates of catheter ablation for atrial fibrillation

机译:心房颤动导管消融的安全性和并发症率的时间趋势

获取原文
获取原文并翻译 | 示例

摘要

Abstract Introduction Atrial fibrillation (AF) ablation is increasingly common, but is associated with potential major complications. Technology, experience, and protocols have evolved significantly in recent times, and may have impacted procedural safety. We sought to compare AF ablation safety profiles, including complication rates and fluoroscopy times in a “modern” versus “historical” cohort. Methods and results We evaluated consecutive patients undergoing AF ablation from a modern cohort (MC) from 2014 to 2015 and a historic cohort (HC) from 2009 to 2011 for complications. Major complications were categorized according to Heart Rhythm Society guidelines. We included 1,425 patients, 726 in the HC and 699 in the MC. The MC was older, had more OSA and less valvular AF. Fifty‐two (3.5%) procedures suffered major complications across the cohorts, with significantly fewer in the MC (5.0%?vs. 2.3%, P??=??0.007). The largest reductions were seen in vascular, hemorrhagic, ischemic stroke, and perforation/tamponade related complications. Periprocedural antiplatelets drugs (aHR 2.1 [95 CI 1.1–3.9], P??=??0.02) and force‐sensing catheters (aHR 0.4 [95 CI 0.2–0.9], P??=??0.03) were independently related to major complication rates. Direct oral anticoagulants and uninterrupted anticoagulation were not associated with complications. There was a decrease in both fluoroscopy (–17.4 minutes [95 CI 19.2–15.6], P??0.0001) and radiofrequency ablation times (?561?seconds [95CI ?750 to ?371], P??0.0001). Conclusions The safety profile of AF ablation has improved significantly in less than a decade.
机译:摘要介绍心房颤动(AF)消融越来越普遍,但与潜在的主要并发症有关。技术,经验和协议在近时显着发展,可能影响程序安全。我们试图比较AF消融安全型材,包括“现代”与“历史”队列中的并发症率和透视时间。方法和结果我们从2014年到2015年到2015年从现代队列(MC)以及2009年到2011年的历史队列(HC)进行了评估的连续患者。根据心律社会指导方针分类主要并发症。我们包括1,425名患者,在MC中HC和699患者726名。 MC年龄较大,有更多的OSA和较少的瓣膜AF。五十二(3.5%)程序遭受了群组的主要并发症,MC中的显着较少(5.0%?VS。2.3%,P ?? = 0.007)。在血管,出血,缺血性卒中和穿孔/局部障碍相关并发症中可以获得最大的降低。 Periprocedury抗血浆药物(AHR 2.1 [95 CI 1.1-3.9],p ?? = ?? 0.02)和力传感导管(AHR 0.4 [95ci 0.2-0.9],p ?? = ?? 0.03)与之独立相关主要的并发症率。直接口服抗凝血剂和不间断的抗凝血与并发症无关。荧光透视减少(-17.4分钟[95ci 19.2-15.6],p≤≤0.0001)和射频消融时间(Δ561?秒[95ci吗?750至α371],p≤≤0.0001 )。结论AF消融的安全性曲线在不到十年内显着提高。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号